FMX103 Approval Status
FDA Approved: No
Brand name: FMX103
Generic name: minocycline
Dosage form: Topical Foam
Company: Foamix Pharmaceuticals Ltd.
Treatment for: Rosacea
FMX103 is a topical minocycline foam formulation in development for the treatment of moderate-to-severe papulopustular rosacea.
Development Status and FDA Approval Process for FMX103
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.